XOMA Acquires Royalty, Milestone Rights for Two Assets From LadRx - Marketscreener.com

LADXDelisted Stock  USD 2.37  0.14  6.28%   
Slightly above 55% of LadRx's investors are presently thinking to get in. The analysis of overall sentiment of trading LadRx otc stock suggests that some investors are interested at this time. LadRx's investing sentiment can be driven by a variety of factors including economic data, LadRx's earnings reports, geopolitical events, and overall market trends.
  
XOMA Acquires Royalty, Milestone Rights for Two Assets From LadRx Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

LadRx Fundamental Analysis

We analyze LadRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LadRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LadRx based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

LadRx is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

LadRx Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LadRx otc stock to make a market-neutral strategy. Peer analysis of LadRx could also be used in its relative valuation, which is a method of valuing LadRx by comparing valuation metrics with similar companies.

Peers

LadRx Related Equities

ARTHArch Therapeutics   36.84   
0%
100.0%
CVKDCadrenal Therapeutics,   11.59   
0%
31.0%
MCRBSeres Therapeutics   6.98   
0%
18.0%
INMInMed Pharmaceuticals   6.28   
0%
17.0%
NBYNovaBay Pharmaceuticals   6.00   
0%
16.0%
TARAProtara Therapeutics   4.05   
0%
10.0%
IOVAIovance Biotherapeutics   2.22   
0%
6.0%
PLXProtalix Biotherapeutics   1.15   
0%
3.0%
PHIOPhio Pharmaceuticals   1.15   
0%
3.0%
GOVXGeoVax Labs   1.29   
3.0%
0%
BVNRYBavarian Nordic   1.34   
3.0%
0%
LXRXLexicon Pharmaceuticals   1.39   
3.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Note that the LadRx information on this page should be used as a complementary analysis to other LadRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in LadRx OTC Stock

If you are still planning to invest in LadRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LadRx's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.